Skip Nav

Clinical Guidelines Portal

Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States

Guidelines Panel Members

(Last updated:7/31/2012; last reviewed:7/31/2012)

Printer-Friendly Files

Members of the Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission

Revisions to the September 14, 2011, Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal Transmission in the United States have been made by the Department of Health and Human Services (HHS) Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission (a Working Group of the Office of AIDS Research Advisory Council).

Members of the Panel

Erika Aaron, MSN, ANP, RNP

Drexel University College of Medicine, Philadelphia, PA

Elaine J. Abrams, MD

Columbia University, New York, NY

Jean Anderson, MD

Johns Hopkins University School of Medicine, Baltimore, MD

Dawn Averitt Bridge, BIS

The Well Project, Charlottesville, VA

Rana Chakraborty, MD, MS, PhD

Emory University School of Medicine, Atlanta, GA

Susan E. Cohn, MD, MPH

Northwestern University Feinberg School of Medicine, Chicago, IL

Susan Cu-Uvin, MD

The Miriam Hospital, Brown University, Providence, RI

Judith Feinberg, MD

University of Cincinnati College of Medicine, Cincinnati, OH

Patricia M. Flynn, MD

St. Jude Children’s Research Hospital, Memphis, TN

Mary Glenn-Fowler, MD, MPH

Johns Hopkins University School of Medicine, Baltimore, MD

Robert Maupin, MD

Louisiana State University Health Sciences Center, New Orleans, LA

Howard Minkoff, MD

Maimonides Medical Center, State University of New York Brooklyn, Brooklyn, NY

Mark Mirochnick, MD

Boston Medical Center, Boston, MA

Fatima Y. Prioleau, MA

Brooklyn, NY

Stephen A. Spector, MD

University of California, San Diego, La Jolla, CA and Rady Children's Hospital, San Diego, CA

Kathleen E. Squires, MD

Thomas Jefferson University, Philadelphia, PA

Meg Sullivan, MD

Boston Medical Center, Boston, MA

Ruth Tuomala, MD

Brigham and Women’s Hospital, Harvard Medical School, Boston, MA

Geoffrey A. Weinberg, MD

University of Rochester School of Medicine and Dentistry, Rochester, NY

Panel Executive Secretary

Lynne Mofenson, MD

National Institutes of Health, Rockville, MD

Ex Officio Member

Jess Waldura, MD

National Perinatal HIV Hotline, San Francisco, CA

Members from the Department of Health and Human Services

Songhai Barclift, MD

Health Resources and Services Administration, Rockville, MD

Brian Feit, MPA

Health Resources and Services Administration, Rockville, MD

Edward Handelsman, MD*

National Institutes of Health, Rockville, MD

Denise Jamieson, MD, MPH

Centers for Disease Control and Prevention, Atlanta, GA

Steve Nesheim, MD

Centers for Disease Control and Prevention, Atlanta, GA

Alan Shapiro, MD, PhD

Food and Drug Administration, Rockville, MD

D. Heather Watts, MD

National Institutes of Health, Rockville, MD

Nonvoting Observers from the Francois-Xavier Bagnound Center

Carolyn Burr, RN, EdD

Francois-Xavier Bagnoud Center, School of Nursing, University of Medicine and Dentistry of New Jersey, Newark, NJ

Deborah Storm, MSN, PhD

Francois-Xavier Bagnoud Center, School of Nursing, University of Medicine and Dentistry of New Jersey, Newark, NJ

* Dr. Handelsman died suddenly on March 4, 2012. He is remembered as a leader in and advocate of pediatric and perinatal HIV research. Panel members hope to honor Dr. Handelsman’s legacy by continuing his work to save the lives of women and children worldwide.